Postpartum Initiation of GLP-1 Receptor Agonists Among Commercially Insured Women in the US.

Postpartum women with commercial insurance in the US have low initiation rates of GLP-1 receptor agonists, with only a small percentage starting treatment after childbirth.

• Why it matters: Understanding postpartum medication use is crucial because this period involves significant health risks and management opportunities for metabolic conditions, yet data on GLP-1 receptor agonist initiation remains limited.
• What they did: The study analyzed cross-sectional data from a large cohort of insured women to determine how many begin GLP-1 receptor agonist therapy during the postpartum period.
• The result: Findings reveal that initiation rates are relatively low, highlighting a potential gap in postpartum metabolic care and the need for targeted interventions to improve treatment uptake.